The third clonal hierarchy encountered in de novo-type AML is designated by specific chromosomal aberrations as the initiating event, often followed by mutations in tyrosine-kinase or RAS pathways, but never associated with the NPM1, CEBPA, RUNX1, or GATA2 mutations. Here, GATA2 is linked to acute myeloid leukemia.